Skip to content
DDReg Pharma
DELIVER BETTER DATA TO ENSURE FASTER APPROVAL
Home
Blogs
Insights
Case Studies
News & Events
Brochures
X
+1 (302) 601-2755
case studies
CASE STUDIES
27
Mar
March 27, 2024
Fulfilling stability data requirements for ANADA filings
15
Feb
February 15, 2024
Customized aRMM for National PV Center in Saudi Arabia
02
Jan
January 2, 2024
Development of Pharmacovigilance Training Modules for US-based Educational Institute
06
Oct
October 6, 2023
Drug-device registration in CIS countries
13
Jun
June 13, 2023
Accelerating access to Women’s Health products
12
Jun
June 12, 2023
Web-based Lifecycle Management Tool
16
Aug
August 16, 2022
Incorporating plug in tools to facilitate publishing tasks
16
Aug
August 16, 2022
Legibility checks to avoid ANDA rejection
16
Aug
August 16, 2022
Gulf Health Council file upload for biosimilar product
12
Jul
July 12, 2021
Worldwide In-Market compliance
12
Jul
July 12, 2021
Introduction of Indian Herbal Pain Patch in the USA
12
Jul
July 12, 2021
POM to P & GSL Switch – First Time for Molecule
10
Jul
July 10, 2021
Development of all-inclusive “Global” DMF
10
Jul
July 10, 2021
Biosimilar Market Authorization in Malaysia
28
Jun
June 28, 2021
UK registration of a formulation of a big global brand, sourced from 3rd party CMO
